Potential applications of global protein expression analysis (proteomics) in morbid obesity and bariatric surgery

被引:9
作者
Brandacher, Gerald [1 ]
Golderer, Georg [2 ]
Kienzl, Katrin [1 ]
Werner, Ernst R. [2 ]
Margreiter, Raimund [1 ]
Weiss, Helmut G. [1 ]
机构
[1] Innsbruck Med Univ, Dept Gen & Transplant Surg, A-6020 Innsbruck, Austria
[2] Innsbruck Med Univ, Bioctr, Div Biol Chem, A-6020 Innsbruck, Austria
关键词
morbid obesity; bariatric surgery; metabolic regulation; biomarkers; proteomics;
D O I
10.1007/s11695-007-9337-2
中图分类号
R61 [外科手术学];
学科分类号
摘要
Global protein expression analysis, known as proteomics, has emerged as a novel scientific technology currently successfully applied to several fields of medicine including cancer and transplantation. Thereby, a thorough exploration of the pathogenic mechanisms and a better understanding of the pathophysiology of diseases as well as identification of diagnostic biomarkers have been achieved. In this paper, we outline the basic principles and potential applications of this promising tool in bariatric surgery where proteomics might hold great potential for new insights into diagnostic and therapeutic decision making based on improved knowledge of metabolic regulations pre- and postsurgical interventions in morbidly obese patients.
引用
收藏
页码:905 / 910
页数:6
相关论文
共 21 条
[1]   Mass spectrometry-based proteomics [J].
Aebersold, R ;
Mann, M .
NATURE, 2003, 422 (6928) :198-207
[2]   A novel experimental design for comparative two-dimensional gel analysis: Two-dimensional difference gel electrophoresis incorporating a pooled internal standard [J].
Alban, A ;
David, SO ;
Bjorkesten, L ;
Andersson, C ;
Sloge, E ;
Lewis, S ;
Currie, I .
PROTEOMICS, 2003, 3 (01) :36-44
[3]   The human plasma proteome - History, character, and diagnostic prospects [J].
Anderson, NL ;
Anderson, NG .
MOLECULAR & CELLULAR PROTEOMICS, 2002, 1 (11) :845-867
[4]   Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework [J].
Atkinson, AJ ;
Colburn, WA ;
DeGruttola, VG ;
DeMets, DL ;
Downing, GJ ;
Hoth, DF ;
Oates, JA ;
Peck, CC ;
Schooley, RT ;
Spilker, BA ;
Woodcock, J ;
Zeger, SL .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (03) :89-95
[5]  
BIMERGRUENBERGE.R, 2007, CURR DRUG DISCOV TEC, V4, P1
[6]   Proteomics as a tool for clinically relevant biomarker discovery and validation [J].
Duncan, MW ;
Hunsucker, SW .
EXPERIMENTAL BIOLOGY AND MEDICINE, 2005, 230 (11) :808-817
[7]   Molecular biologist's guide to proteomics [J].
Graves, PR ;
Haystead, TAJ .
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, 2002, 66 (01) :39-+
[8]   Proteomics and disease: opportunities and challenges [J].
Kavallaris, M ;
Marshall, GM .
MEDICAL JOURNAL OF AUSTRALIA, 2005, 182 (11) :575-579
[9]   Profiling of adipokines secreted from human subcutaneous adipose tissue in response to PPAR agonists [J].
Klimcakova, Eva ;
Moro, Cedric ;
Mazzucotelli, Anne ;
Lolmede, Karine ;
Viguerie, Nathalle ;
Galitzky, Jean ;
Stich, Vladimir ;
Langin, Dominique .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 358 (03) :897-902
[10]   Surgical treatment of obesity [J].
Kral, John G. ;
Naslund, Erik .
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2007, 3 (08) :574-583